160 related articles for article (PubMed ID: 26902100)
1. In situ validation of VEGFR-2 and α v ß 3 integrin as targets for breast lesion characterization.
Ehling J; Misiewicz M; von Stillfried S; Möckel D; Bzyl J; Pochon S; Lederle W; Knuechel R; Lammers T; Palmowski M; Kiessling F
Angiogenesis; 2016 Apr; 19(2):245-254. PubMed ID: 26902100
[TBL] [Abstract][Full Text] [Related]
2. Comparison of [
Chen Z; Fu F; Li F; Zhu Z; Yang Y; Chen X; Jia B; Zheng S; Huang C; Miao W
Mol Imaging Biol; 2018 Oct; 20(5):846-856. PubMed ID: 29497956
[TBL] [Abstract][Full Text] [Related]
3. FAS1 domain protein inhibits VEGF165-induced angiogenesis by targeting the interaction between VEGFR-2 and αvβ3 integrin.
Nam JO; Son HN; Jun E; Cha K; Lee BH; Park RW; Kim IS
Mol Cancer Res; 2012 Aug; 10(8):1010-20. PubMed ID: 22710795
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis.
Mahabeleshwar GH; Feng W; Reddy K; Plow EF; Byzova TV
Circ Res; 2007 Sep; 101(6):570-80. PubMed ID: 17641225
[TBL] [Abstract][Full Text] [Related]
5. Angiomodulin, a marker of cancer vasculature, is upregulated by vascular endothelial growth factor and increases vascular permeability as a ligand of integrin αvβ3.
Komiya E; Sato H; Watanabe N; Ise M; Higashi S; Miyagi Y; Miyazaki K
Cancer Med; 2014 Jun; 3(3):537-49. PubMed ID: 24737780
[TBL] [Abstract][Full Text] [Related]
6. Acquired expression of periostin by human breast cancers promotes tumor angiogenesis through up-regulation of vascular endothelial growth factor receptor 2 expression.
Shao R; Bao S; Bai X; Blanchette C; Anderson RM; Dang T; Gishizky ML; Marks JR; Wang XF
Mol Cell Biol; 2004 May; 24(9):3992-4003. PubMed ID: 15082792
[TBL] [Abstract][Full Text] [Related]
7. Imaging VEGF Receptors and α
Tekabe Y; Li Q; Zhang G; Johnson J; Schmidt AM; Backer M; Backer J; Johnson LL
Mol Imaging Biol; 2018 Dec; 20(6):963-972. PubMed ID: 29687324
[TBL] [Abstract][Full Text] [Related]
8. Breast lesion characterization using whole-lesion histogram analysis with stretched-exponential diffusion model.
Liu C; Wang K; Li X; Zhang J; Ding J; Spuhler K; Duong T; Liang C; Huang C
J Magn Reson Imaging; 2018 Jun; 47(6):1701-1710. PubMed ID: 29165847
[TBL] [Abstract][Full Text] [Related]
9. [Expression of vascular endothelial growth factor receptor 3 in human breast cancer and its significance].
Wu J; Chen L; Zhou W; Liu X; Chen X; Miao D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Dec; 27(12):1487-91. PubMed ID: 24640372
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.
Willmann JK; Lutz AM; Paulmurugan R; Patel MR; Chu P; Rosenberg J; Gambhir SS
Radiology; 2008 Sep; 248(3):936-44. PubMed ID: 18710985
[TBL] [Abstract][Full Text] [Related]
11. Localization of integrin alpha(v)beta3 and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in cutaneous and oral melanomas of dog.
Rawlings NG; Simko E; Bebchuk T; Caldwell SJ; Singh B
Histol Histopathol; 2003 Jul; 18(3):819-26. PubMed ID: 12792894
[TBL] [Abstract][Full Text] [Related]
12. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk.
Wang L; Zhang X; Pang N; Xiao L; Li Y; Chen N; Ren M; Deng X; Wu J
Cell Death Dis; 2015 Jun; 6(6):e1796. PubMed ID: 26111058
[TBL] [Abstract][Full Text] [Related]
13. Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells.
Montenegro CF; Salla-Pontes CL; Ribeiro JU; Machado AZ; Ramos RF; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2012 Aug; 94(8):1812-20. PubMed ID: 22561350
[TBL] [Abstract][Full Text] [Related]
14. High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer.
Ghosh S; Sullivan CA; Zerkowski MP; Molinaro AM; Rimm DL; Camp RL; Chung GG
Hum Pathol; 2008 Dec; 39(12):1835-43. PubMed ID: 18715621
[TBL] [Abstract][Full Text] [Related]
15. Variable effects of alpha v suppression on VEGFR-2 expression in endothelial cells of different vascular beds.
Dardik R; Livnat T; Seligsohn U
Thromb Haemost; 2009 Nov; 102(5):975-82. PubMed ID: 19888537
[TBL] [Abstract][Full Text] [Related]
16. Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET.
Beer AJ; Niemeyer M; Carlsen J; Sarbia M; Nährig J; Watzlowik P; Wester HJ; Harbeck N; Schwaiger M
J Nucl Med; 2008 Feb; 49(2):255-9. PubMed ID: 18199623
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and alphavbeta3 integrin.
Papo N; Silverman AP; Lahti JL; Cochran JR
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14067-72. PubMed ID: 21825147
[TBL] [Abstract][Full Text] [Related]
18. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.
Valtola R; Salven P; Heikkilä P; Taipale J; Joensuu H; Rehn M; Pihlajaniemi T; Weich H; deWaal R; Alitalo K
Am J Pathol; 1999 May; 154(5):1381-90. PubMed ID: 10329591
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.
Rapraeger AC; Ell BJ; Roy M; Li X; Morrison OR; Thomas GM; Beauvais DM
FEBS J; 2013 May; 280(10):2194-206. PubMed ID: 23331867
[TBL] [Abstract][Full Text] [Related]
20. AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.
Vellon L; Menendez JA; Lupu R
Oncogene; 2005 May; 24(23):3759-73. PubMed ID: 15782133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
